Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review
Taryn B. Bainum, Kelly R. Reveles, Ronald G. Hall, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 387-387
Open Access | Times Cited: 21

Showing 21 citing articles:

Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications
Nityanand Jain, Tungki Pratama Umar, Anne-Fleur Fahner, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details
Lea Monday, Glenn Tillotson, Teena Chopra
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 623-639
Open Access | Times Cited: 5
Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review
Shiju Chen, Daya Zhang, Da Li, et al.
Medicine (2025) Vol. 104, Iss. 4, pp. e41262-e41262
Open Access
Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection
Krista Vitikainen, M Kase, Leo Meriranta, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA
Hannah A. Blair
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 10, pp. 331-338
Open Access | Times Cited: 4
Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
Lynne V. McFarland, Ellie J. C. Goldstein, Ravina Kullar
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1534-1534
Open Access | Times Cited: 3
Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Clostridioides difficile Toxin A and Toxin B
Katia Fettucciari, Fabrizio Dini, P Marconi, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1117-1117
Open Access | Times Cited: 3
Clostridium difficile Infection: Analysis of 5-Year Data in an Italian University Hospital
Emanuela Santoro, Roberta Manente, Mario Capunzo, et al.
Infectious Diseases Diagnosis & Treatment (2024) Vol. 8, Iss. 1
Open Access
Protective Effects of Huo Xiang Zheng Qi Liquid on Clostridioides difficile Infection on C57BL/6 Mice
Ming Chen, Lin Zhai, Kristian Schønning, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1602-1602
Open Access
Alternative treatment of recurrent Clostridioides difficile infection in adults by fecal transplantation: an overview of phase I–IV studies from Clinicaltrials.gov
Najla A. Obaid
Frontiers in Microbiology (2024) Vol. 15
Open Access
PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells
Sandra Buratta, Lorena Urbanelli, Roberto Maria Pellegrino, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1103-1103
Open Access
More than a new name
Alexander F. Wrynn
The Nurse Practitioner (2024) Vol. 49, Iss. 8, pp. 14-19
Open Access
Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review
Vignesh Krishnan Nagesh, Hadrian Hoang-Vu Tran, Daniel Eliáš, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics (2024) Vol. 15, Iss. 5
Open Access
Colites postantibiotiques
Lian Gan, D. Delarbre, Marie‐Pierre Otto, et al.
EMC - Gastro-entérologie (2024) Vol. 41, Iss. 4, pp. 1-12
Closed Access
The conundrum of bacteria-specific antibiotics
Santanu Datta
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 6, pp. 1354-1358
Open Access | Times Cited: 1
In-vitro determination of inhibitory effects of probiotic strains on Clostridioides difficile
Gizem Taylan Yalçın, Melike Nur Tosun, Nükhet Nilüfer Demirel Zorba
Anaerobe (2023) Vol. 81, pp. 102737-102737
Closed Access | Times Cited: 1
The Design, Synthesis, and Inhibition of Clostridioides difficile Spore Germination by Acyclic and Bicyclic Tertiary Amide Analogs of Cholate
Shiv K. Sharma, Angel Schilke, Jacqueline R. Phan, et al.
(2023)
Open Access
5,6-Fused Heterocycle Cholate Derivatives as Spore Germination Inhibitors of Clostridioides difficile
Shiv K. Sharma, Jacqueline R. Phan, Ernesto Abel‐Santos, et al.
(2023)
Open Access
The design, synthesis, and inhibition of Clostridioides difficile spore germination by acyclic and bicyclic tertiary amide analogs of cholate
Shiv K. Sharma, Angel Schilke, Jacqueline R. Phan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115788-115788
Open Access
Primum Non Nocere: Time to Rethink Probiotic Therapy*
Brooke K. Decker
Critical Care Medicine (2023) Vol. 51, Iss. 11, pp. 1592-1593
Open Access
Bakterielle und virale Infektionserkrankungen und Mykosen
Winfried V. Kern
Springer eBooks (2023), pp. 391-414
Closed Access
Page 1

Scroll to top